PATTI, Giuseppe Rocco Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 5.826
AS - Asia 3.065
EU - Europa 2.641
SA - Sud America 441
AF - Africa 41
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.027
Nazione #
US - Stati Uniti d'America 5.765
SG - Singapore 1.218
IE - Irlanda 1.141
CN - Cina 906
RU - Federazione Russa 422
BR - Brasile 392
DE - Germania 388
UA - Ucraina 384
HK - Hong Kong 378
TR - Turchia 333
IT - Italia 107
IN - India 80
VN - Vietnam 47
FR - Francia 42
GB - Regno Unito 35
CA - Canada 30
BD - Bangladesh 26
SE - Svezia 25
MX - Messico 21
JP - Giappone 20
AR - Argentina 19
FI - Finlandia 19
IQ - Iraq 18
BE - Belgio 17
PL - Polonia 16
ZA - Sudafrica 14
EC - Ecuador 10
ES - Italia 8
VE - Venezuela 8
AT - Austria 7
MA - Marocco 7
NL - Olanda 7
PK - Pakistan 7
AU - Australia 6
JO - Giordania 6
LT - Lituania 6
EU - Europa 5
ID - Indonesia 5
HU - Ungheria 4
KE - Kenya 4
PY - Paraguay 4
SA - Arabia Saudita 4
UY - Uruguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
JM - Giamaica 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HT - Haiti 1
IR - Iran 1
KR - Corea 1
LY - Libia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
Totale 12.027
Città #
Jacksonville 1.490
Dublin 1.139
Chandler 821
Dallas 586
Singapore 540
Santa Clara 397
Hong Kong 378
Izmir 317
Nanjing 312
Ashburn 193
Boardman 193
Lawrence 189
Princeton 189
Wilmington 130
Moscow 126
Nanchang 104
New York 103
The Dalles 91
L'aquila 85
Columbus 61
Council Bluffs 54
Pune 54
Shenyang 53
Los Angeles 52
Beijing 45
Hebei 42
Tianjin 40
Jiaxing 31
San Mateo 30
Kunming 29
Norwalk 29
São Paulo 28
Changsha 27
Shanghai 22
Ann Arbor 20
Jinan 20
Munich 20
Tokyo 19
Brussels 17
Lanzhou 17
Ho Chi Minh City 15
Montreal 15
Mountain View 15
Warsaw 14
Hanoi 13
Zhengzhou 13
London 12
Helsinki 11
Rio de Janeiro 11
Brooklyn 10
Changchun 10
Ningbo 10
Atlanta 9
Brasília 9
Johannesburg 9
Manchester 9
Mexico City 9
Belo Horizonte 8
Denver 8
Porto Alegre 8
San Francisco 8
Stockholm 8
Curitiba 7
Des Moines 7
Phoenix 7
Buenos Aires 6
Campinas 6
Chennai 6
Dhaka 6
Istanbul 6
Toronto 6
Amman 5
Baghdad 5
Boston 5
Chicago 5
Fremont 5
Hangzhou 5
Lappeenranta 5
New Delhi 5
Quito 5
Redwood City 5
Vienna 5
Ankara 4
Erbil 4
Falkenstein 4
Frankfurt am Main 4
Guangzhou 4
Jakarta 4
Joinville 4
Milwaukee 4
Montevideo 4
Nuremberg 4
Rome 4
Salvador 4
Seattle 4
Secaucus 4
Tashkent 4
Uberlândia 4
Amsterdam 3
Arapiraca 3
Totale 8.509
Nome #
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis 122
Author`s Reply 114
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 103
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 102
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 100
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 99
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? 99
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis 96
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 91
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 90
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment. 88
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 87
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 87
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: The prospective, multicentre observational PREvention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) 87
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial 85
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 85
Left atrial and auricular thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 84
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 84
Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 84
Atorvastatin for reduction of myocardial damage during angioplasty trials 84
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 83
Have statins beneficial anti-inflammatory as well as lipid-lowering effects 80
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 80
Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question! 80
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 79
Apoptosis in recent myocardial infarction 78
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly 77
Myocardial infarction during pregnancy and postpartum: A review 77
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 76
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 76
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 76
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. 76
Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents 76
Early and long-term results of stenting of diffuse coronary artery disease 75
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 75
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 75
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 75
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 74
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 74
Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale 74
Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study 73
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 73
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study 73
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 73
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations 72
Apoptosis and post-infarction left ventricular remodeling 72
Are we ready for a gender-specific approach in interventional cardiology? 72
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 72
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 72
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 72
Improvement of myocardial ischemia by subclavian stent implantation in patients with internal mammary grafts: A case report and review of the literature 72
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 71
Prasugrel versus clopidogrel 71
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 71
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 71
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention 70
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 70
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 70
Patients with atrial fibrillation and coronary events: Are we any closer to coming out from the labyrinth of the various antithrombotic strategies? 70
Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina 69
Key references: Basic fibrinolysis and thrombolysis selected references: 1987-1997 69
Atorvastatin pretreatment in early percutaneous coronary intervention 69
The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation 69
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: An unusual case of myocardial rupture 69
The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences 68
Coronary stenting in patients with depressed left ventricular function: Acute and long-term results in a selected population 68
Platelets GP-IIB-IIA receptor inhibitors in ischemic patients 68
Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis 68
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention - Results from the ARMYDA-2 (Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty) study 68
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction 68
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 68
Comparison of the Feasibility and Effectiveness of Transradial Coronary Angiography Via Right Versus Left Radial Artery Approaches (from the PREVAIL Study) 67
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 67
Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study 67
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 67
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy 67
Untitled 66
Association of virulent Helicobacter pylori strains with ischemic heart disease 66
Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery 66
Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass 66
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 66
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 66
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study) 66
Inflammatory markers and coronary interventions: A potentially useful follow-up modality after stenting 66
Combining Antiplatelet and Anticoagulant Therapies 66
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 66
Percutaneous coronary interventions and statin therapy 65
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients 65
Chapter "Chronobiology of the haemostatic system", for the book “Physiology and pharmacology of biological rhythms” (Editors P. H. Redfern e B. Lemmer) (Springer) 65
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials 65
Statin loading for acute coronary syndromes 65
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 64
Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis 64
Platelet function and inhibition in ischemic heart disease 64
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 64
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention 64
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 64
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 63
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 63
Prevention of myocardial damage during coronary intervention 63
Totale 7.481
Categoria #
all - tutte 66.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021593 0 0 0 0 0 1 198 1 176 1 216 0
2021/2022509 1 0 5 5 15 3 9 61 68 5 84 253
2022/20232.682 218 87 46 211 196 239 0 159 1.387 11 78 50
2023/2024483 98 25 31 22 39 192 2 39 0 24 2 9
2024/20252.765 22 31 273 55 258 308 389 142 760 139 194 194
2025/20262.068 251 456 414 424 325 198 0 0 0 0 0 0
Totale 12.250